Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention

NCT05947539 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-12-26

No results posted yet for this study

Summary

This study will develop and pilot test a couples-based intervention to help adolescent girls and young women living with HIV (WLHIV (15-24 years) living in Uganda access HIV care and improve the outcomes of their HIV treatment by targeting male partner alcohol use to reduce IPV risk.

Conditions

Interventions

BEHAVIORAL

Kisoboka Mukwano ("It is possible, my love!") Intervention

The intervention consists of 5 bi-weekly sessions each lasting 60 to 90 minutes. It uses motivational interviewing, peer navigation, and behavioral economics to promote strategies for economic strengthening, reductions in male partner alcohol use, coping with relationship conflict and stress, changing norms that reduce intimate partner violence and support engagement in HIV care and antiretroviral therapy (ART) adherence among adolescent girls and young women living with HIV, and, thereby, enhances future sustained viral suppression and benefits of treatment as prevention.

BEHAVIORAL

Screening and Referral

Intimate partner violence screening, alcohol screening, and referral

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH
  • San Diego State University

    collaborator OTHER
  • Makerere University

    collaborator OTHER
  • University of California, San Diego

    collaborator OTHER
  • Reach the Youth Uganda

    collaborator OTHER
  • Arizona State University

    lead OTHER

Principal Investigators

  • Ijeoma Nwabuzor Ogbonnaya, PhD · Arizona State University

  • Susan M Kiene, PhD · San Diego State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2026-10-30
Completion
2026-10-30

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05947539 on ClinicalTrials.gov